Abstract:Campylobacter jejuni is a prevalent human pathogen and a major cause of bacterial gastroenteritis in the world. In humans, C. jejuni colonizes the intestinal tract and its tolerance to bile is crucial for bacteria to survive and establish infection. C. jejuni produces outer membrane vesicles (OMVs) which have been suggested to be involved in virulence. In this study, the proteome composition of C. jejuni OMVs in response to low concentration of bile was investigated. We showed that exposure of C. jejuni to low… Show more
“…Both the mlaA mutant OMVs and wild-type ST-OMVs had comparable diameters. This is in contrast to data from a recent study (Taheri et al, 2018) which did not observe increased OMV production in response to ox bile. Ox bile was used to represent a mixture of bile salts, similar to what would be found in the gut, whereas ST alone was used in this study, a single component of human bile.…”
Campylobacter jejuni
outer membrane vesicles (OMVs) contain numerous virulence-associated proteins including the cytolethal distending toxin and three serine proteases. As
C. jejuni
lacks the classical virulence-associated secretion systems of other enteric pathogens that deliver effectors directly into target cells, OMVs may have a particularly important role in virulence.
C. jejuni
OMV production is stimulated by the presence of physiological concentrations of the bile salt sodium taurocholate (ST) through an unknown mechanism. The maintenance of lipid asymmetry (MLA) pathway has been implicated in a novel mechanism for OMV biogenesis, open to regulation by host signals. In this study we investigated the role of the MLA pathway in
C. jejuni
OMV biogenesis with ST as a potential regulator. OMV production was quantified by analyzing protein and lipid concentrations of OMV preparations and OMV particle counts produced by nanoparticle tracking analysis. Mutation of
mlaA
which encodes the outer membrane component of the MLA pathway significantly increased OMV production compared to the wild-type strain. Detergent sensitivity and membrane permeability assays confirmed the increased OMV production was not due to changes in membrane stability. The presence of 0.2% (w/v) ST increased wild-type OMV production and reduced OMV size, but did not further stimulate
mlaA
mutant OMV production or significantly alter
mlaA
mutant OMV size. qRT-PCR analysis demonstrated that the presence of ST decreased expression of both
mlaA
and
mlaC
in
C. jejuni
wild-type strains 11168 and 488. Collectively the data in this study suggests
C. jejuni
can regulate OMV production in response to host gut signals through changes in expression of the MLA pathway. As the gut bile composition is dependent on both diet and the microbiota, this study highlights the potential importance of diet and lifestyle factors on the varying disease presentations associated with gut pathogen infection.
“…Both the mlaA mutant OMVs and wild-type ST-OMVs had comparable diameters. This is in contrast to data from a recent study (Taheri et al, 2018) which did not observe increased OMV production in response to ox bile. Ox bile was used to represent a mixture of bile salts, similar to what would be found in the gut, whereas ST alone was used in this study, a single component of human bile.…”
Campylobacter jejuni
outer membrane vesicles (OMVs) contain numerous virulence-associated proteins including the cytolethal distending toxin and three serine proteases. As
C. jejuni
lacks the classical virulence-associated secretion systems of other enteric pathogens that deliver effectors directly into target cells, OMVs may have a particularly important role in virulence.
C. jejuni
OMV production is stimulated by the presence of physiological concentrations of the bile salt sodium taurocholate (ST) through an unknown mechanism. The maintenance of lipid asymmetry (MLA) pathway has been implicated in a novel mechanism for OMV biogenesis, open to regulation by host signals. In this study we investigated the role of the MLA pathway in
C. jejuni
OMV biogenesis with ST as a potential regulator. OMV production was quantified by analyzing protein and lipid concentrations of OMV preparations and OMV particle counts produced by nanoparticle tracking analysis. Mutation of
mlaA
which encodes the outer membrane component of the MLA pathway significantly increased OMV production compared to the wild-type strain. Detergent sensitivity and membrane permeability assays confirmed the increased OMV production was not due to changes in membrane stability. The presence of 0.2% (w/v) ST increased wild-type OMV production and reduced OMV size, but did not further stimulate
mlaA
mutant OMV production or significantly alter
mlaA
mutant OMV size. qRT-PCR analysis demonstrated that the presence of ST decreased expression of both
mlaA
and
mlaC
in
C. jejuni
wild-type strains 11168 and 488. Collectively the data in this study suggests
C. jejuni
can regulate OMV production in response to host gut signals through changes in expression of the MLA pathway. As the gut bile composition is dependent on both diet and the microbiota, this study highlights the potential importance of diet and lifestyle factors on the varying disease presentations associated with gut pathogen infection.
“…[185] indirectly confirmed the abovementioned findings by Taheri et al. [184] using bile salt sodium taurocholate. After treatment with this bile salt, C. jejuni outer MV production increased, with increased MVs‐associated proteolytic activity as a consequence.…”
“…According to Taheri et al [176] composition of the C. jejuni MVs depends on growth temperature and it has implications for the outcome of colonization and pathogenicity of this bacterium in different hosts. Elmi et al [185] indirectly confirmed the abovementioned findings by Taheri et al [184] using bile salt sodium taurocholate. After treatment with this bile salt, C. jejuni outer MV production increased, with increased MVs-associated proteolytic activity as a consequence.…”
Section: Gram Negative Bacteriamentioning
confidence: 57%
“…Proteomics analyses have demonstrated that C. jejuni MVs contain proteins from the periplasm, outer membrane-associated proteins, as well as cytoplasmic proteins that are essential for both survival and pathogenesis of this foodborne bacterium [176,177,183]. Cleavage of host cells' proteins E-cadherin and occludin enhance bacterial invasion into host epithelial cells [181,182], and MVs isolated from in vitro bile treated bacteria also enhance this process [184]. According to Taheri et al [176] composition of the C. jejuni MVs depends on growth temperature and it has implications for the outcome of colonization and pathogenicity of this bacterium in different hosts.…”
Biofilm formation and extracellular microvesicles-The way of foodborne pathogens toward resistance Almost all known foodborne pathogens are able to form biofilms as one of the strategies for survival under harsh living conditions, to ward off the inhibition and the disinfection during food production, transport and storage, as well as during cleaning and sanitation of corresponding facilities. Biofilms are communities where microbial cells live under constant intracellular interaction and communication. Members of the biofilm community are embedded into extracellular matrix that contains polysaccharides, DNA, lipids, proteins, and small molecules that protect microorganisms and enable their intercellular communication under stress conditions. Membrane vesicles (MVs) are produced by both Gram positive and Gram negative bacteria. These lipid membrane-enveloped nanoparticles play an important role in biofilm genesis and in communication between different biofilm members. Furthermore, MVs are involved in other important steps of bacterial life like cell wall modeling, cellular division, and intercellular communication. They also carry toxins and virulence factors, as well as nucleic acids and different metabolites, and play a key role in host infections. After entering host cells, MVs can start many pathologic processes and cause serious harm and cell death. Prevention and inhibition of both biofilm formation and shedding of MVs by foodborne pathogens has a very important role in food production, storage, and food safety in general. Better knowledge of biofilm formation and maintaining, as well as the role of microbial vesicles in this process and in the process of host cells' infection is essential for food safety and prevention of both food spoilage and host infection.
“…In addition, a similar route of MV formation has been suggested in Stenotrophomonas maltophilia, as production of O-IMVs and phages was detected in response to ciprofloxacin stress (Devos et al, 2017). The involvement of cell lysis in MV formation would explain why inner membrane and cytoplasmic components are detected in many proteomic analyses of OMV fractions (Kulkami et al, 2014;Olaya-Abril et al, 2014;Oliver et al, 2017;Avila-Calderón et al, 2018;Taheri et al, 2018).…”
Section: Composition and Biogenesis Of Bacterial Mvsmentioning
Membrane vesicles (MVs) are nanoparticles composed of lipid membranes that are produced by both Gram-negative and Gram-positive bacteria. MVs have been assigned diverse biological functions, and they show great potential for applications in various fields. However, the mechanisms underlying their functions and biogenesis are not completely understood. Accumulating evidence shows that MVs are heterogenous, and different types of MVs with different compositions are released from the same species. To understand the origin and function of these MVs, determining the biochemical properties of MVs is important. In this review, we will discuss recent progress in understanding the biochemical composition and properties of MVs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.